184 related articles for article (PubMed ID: 32194780)
1. Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways.
Ning N; Liu S; Liu X; Tian Z; Jiang Y; Yu N; Tan B; Feng H; Feng X; Zou L
J Cancer; 2020; 11(7):1679-1692. PubMed ID: 32194780
[TBL] [Abstract][Full Text] [Related]
2. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
[TBL] [Abstract][Full Text] [Related]
4. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
5. MiR-5195-3p targets the PCBP2/PI3K/AKT pathway to inhibit melanoma cell proliferation and migration.
Yang B; Wu Y; Chen Y; Li Y; Wang J; Cha X; Liu J
Heliyon; 2023 Sep; 9(9):e19227. PubMed ID: 37662755
[TBL] [Abstract][Full Text] [Related]
6. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-17-3p promotes keratinocyte cells growth and metastasis via targeting MYOT and regulating Notch1/NF-κB pathways.
Yan H; Song K; Zhang G
Pharmazie; 2017 Sep; 72(9):543-549. PubMed ID: 29441982
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
Lv X; Li CY; Han P; Xu XY
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
[TBL] [Abstract][Full Text] [Related]
9. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
[TBL] [Abstract][Full Text] [Related]
10. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
Akgun S; Kucuksayan H; Ozes ON; Can O; Alikanoglu AS; Yildiz M; Akca H
Anticancer Agents Med Chem; 2019; 19(8):1058-1068. PubMed ID: 30727918
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.
Qiang J; Lv T; Wu Z; Yang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239367
[TBL] [Abstract][Full Text] [Related]
12. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
Li Z; Tang X; Duan S
Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
16.
Cao C; Su Y; Gao Y; Luo C; Yin L; Zhao Y; Chen H; Xu A
Evid Based Complement Alternat Med; 2018; 2018():4969028. PubMed ID: 30046339
[TBL] [Abstract][Full Text] [Related]
17. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
19. MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.
Zhao Y; Xie Z; Lin J; Liu P
Am J Transl Res; 2017; 9(5):2437-2446. PubMed ID: 28559994
[TBL] [Abstract][Full Text] [Related]
20. miR-296-3p targets APEX1 to suppress cell migration and invasion of non-small-cell lung cancer.
Wang L; Chen R; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2612-2618. PubMed ID: 31402954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]